Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/11/1997 | US5686259 Assay method for the detection of 26kd TNF prohormone |
11/11/1997 | US5686253 Method of stabilizing enzyme conjugates |
11/11/1997 | US5686248 Fungal stress proteins |
11/11/1997 | US5686245 Methods for screening for agents which modulate telomere length |
11/11/1997 | US5686115 Poly-β-1→4-N-acetylucosamine copolymer composition with collagen |
11/11/1997 | US5686080 Parasitic helminth p4 proteins |
11/11/1997 | US5686079 Oral immunization by transgenic plants |
11/11/1997 | US5686076 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
11/11/1997 | US5686069 Protein toxins active against lepidopteran pests |
11/11/1997 | US5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
11/09/1997 | CA2184763A1 Mutant aequorea victoria fluorescent proteins having increased cellular fluorescence |
11/06/1997 | WO1997041443A2 Method for screening compounds |
11/06/1997 | WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology |
11/06/1997 | WO1997041245A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
11/06/1997 | WO1997041244A1 Vaccines for treatment of lymphoma and leukemia |
11/06/1997 | WO1997041243A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
11/06/1997 | WO1997041232A1 Antagonists of interleukin-15 |
11/06/1997 | WO1997041230A2 Cc-type chemokines |
11/06/1997 | WO1997041229A1 Antibodies against interferon alpha/beta receptor |
11/06/1997 | WO1997041227A1 Plasmid-based vaccine for treating atherosclerosis |
11/06/1997 | WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
11/06/1997 | WO1997041224A1 Human hematopoietic stem and progenitor cell antigen and methods for its use |
11/06/1997 | WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
11/06/1997 | WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
11/06/1997 | WO1997041209A1 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits |
11/06/1997 | WO1997041208A1 Skin regeneration using mesenchymal stem cells |
11/06/1997 | WO1997041156A1 Novel compounds |
11/06/1997 | WO1997041154A1 Eosinophil eotaxin receptor |
11/06/1997 | WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | WO1997041146A1 Novel compounds |
11/06/1997 | WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | WO1997040851A1 Novel compounds |
11/06/1997 | WO1997040679A1 Methods for delivering compounds into a cell |
11/06/1997 | WO1997024452A3 Toxic-protein expressing viruses and producer cell lines |
11/06/1997 | DE19617687A1 Verfahren zur Herstellung transgener, Inulin erzeugender Pflanzen A method for producing transgenic, inulin-producing plants |
11/06/1997 | CA2253724A1 Skin regeneration using mesenchymal stem cells |
11/06/1997 | CA2253595A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
11/06/1997 | CA2253433A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | CA2252850A1 Eosinophil eotaxin receptor |
11/06/1997 | CA2252617A1 Methods for delivering compounds into a cell |
11/06/1997 | CA2252557A1 Antagonists of interleukin-15 |
11/06/1997 | CA2252524A1 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits |
11/06/1997 | CA2252432A1 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
11/06/1997 | CA2250759A1 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
11/06/1997 | CA2250428A1 Plasmid-based vaccine for treating atherosclerosis |
11/05/1997 | EP0805209A2 Nucleic acid construct with genes coding for transportsignals |
11/05/1997 | EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met |
11/05/1997 | EP0804728A1 Assay, receptor proteins and ligands |
11/05/1997 | EP0804727A1 In vitro angiogenesis assay |
11/05/1997 | EP0804617A1 Bcl-x/bcl-2 associated cell death regulator |
11/05/1997 | EP0804614A1 Culture and isolation of fetal cells from maternal peripheral blood |
11/05/1997 | EP0804604A2 Method to improve screening efficiency in fused cells |
11/05/1997 | EP0804600A1 The cytoplasmic inhibition of gene expression |
11/05/1997 | EP0804599A1 Mannose or xylose based positive selection |
11/05/1997 | EP0804593A1 Recombinant hk2 polypeptide |
11/05/1997 | EP0804591A1 Serum paraoxonase |
11/05/1997 | EP0804590A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
11/05/1997 | EP0804586A2 $g(b)-KETOACYL ACP REDUCTASE GENES FROM BRASSICA NAPUS |
11/05/1997 | EP0804583A2 Lettuce infectious yellows virus genes |
11/05/1997 | EP0804579A1 Antibodies which bind to insect gut proteins and their use |
11/05/1997 | EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor |
11/05/1997 | EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR |
11/05/1997 | EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof |
11/05/1997 | EP0804572A1 Protein tyrosine kinase agonist antibodies |
11/05/1997 | EP0804571A1 Spider neurotoxins and method of producing the same |
11/05/1997 | EP0804569A2 Expression of human d 4? dopamine receptors in stable cell lines |
11/05/1997 | EP0804565A1 Tetracycline-regulated transcriptional modulators |
11/05/1997 | EP0804564A1 Neural axon outgrowth modulators |
11/05/1997 | EP0804562A1 Connective tissue growth factor-2 |
11/05/1997 | EP0804561A1 Regulated transcription of targeted genes and other biological events |
11/05/1997 | EP0804556A1 Protein modifying enzyme |
11/05/1997 | EP0804555A1 A monoclonal antibody to human ventricular myosin light chains |
11/05/1997 | EP0804554A1 Preparation of immortalized cells |
11/05/1997 | EP0804553A1 Conditionally immortalized germ cell lines |
11/05/1997 | EP0804552A1 Redirection of cellular immunity by receptor chimeras |
11/05/1997 | EP0804551A1 Bone precursor cells: compositions and methods |
11/05/1997 | EP0804550A1 Ex vivo activation of immune cells |
11/05/1997 | EP0804549A1 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
11/05/1997 | EP0804548A1 Patched genes and their use |
11/05/1997 | EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
11/05/1997 | EP0804546A1 Human prostatic specific reductase |
11/05/1997 | EP0804487A2 Bispecific antigen-binding molecules |
11/05/1997 | EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
11/05/1997 | EP0804482A1 Cytokines that bind the cell surface receptor hek |
11/05/1997 | EP0804479A1 Method of treating diabetes mellitus using kgf |
11/05/1997 | EP0804458A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
11/05/1997 | EP0804457A1 Modified green fluorescenct proteins |
11/05/1997 | EP0804452A1 Recombinant c140 receptor and its agonists and antagonists |
11/05/1997 | EP0804244A1 Compositions including heme-containing proteins and methods relating thereto |
11/05/1997 | EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
11/05/1997 | EP0804233A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
11/05/1997 | EP0804230A1 Vaccine against mycobacterial infections |
11/05/1997 | EP0804226A1 Human choline acetyltransferase |
11/05/1997 | EP0804219A1 Inhibin compositions and methods of use thereof |
11/05/1997 | EP0804218A1 Product and process for regulating signal transduction pathways |
11/05/1997 | EP0804214A1 Growth differentiation factor-6 |
11/05/1997 | EP0804210A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells |
11/05/1997 | EP0804163A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
11/05/1997 | EP0804074A1 Treating red blood cell solutions with anti-viral agents |